Regulation of DNA Replication Licensing and Re-Replication by Cdt1
1Department of Chemistry and Biochemistry, Nevada Institute of Personalized Medicine, University of Nevada, Las Vegas, 4505 South Maryland Parkway, Box 454003, Las Vegas, NV 89154, USA.
International Journal of Molecular Sciences
|June 2, 2021
Summary
DNA replication licensing prevents re-replication by degrading Cdt1 protein via CRL4Cdt2 E3 ligase. Both Cdt1 and CRL4Cdt2 bind PCNA, recruiting the ligase to DNA for Cdt1 destruction.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- DNA replication licensing ensures genome duplication occurs once per cell cycle.
- Cdt1 protein is essential for origin licensing but must be degraded to prevent re-replication.
- CRL4Cdt2 E3 ligase targets Cdt1 for degradation in S phase.
Purpose of the Study:
- To elucidate the mechanism of Cdt1 degradation by CRL4Cdt2.
- To investigate the role of PCNA in recruiting Cdt1 and CRL4Cdt2 to DNA.
- To understand how Cdt1 degradation prevents DNA re-replication.
Main Methods:
- Biochemical assays to study protein-protein interactions.
- Cellular localization studies.
- Ubiquitination and degradation assays.
Main Results:
- Cdt1 and CRL4Cdt2 share a PCNA-binding motif (PIP box-like domain).
- PCNA recruits both Cdt1 and CRL4Cdt2 to replicating DNA.
- This recruitment facilitates Cdt1 ubiquitination and degradation by CRL4Cdt2.
Conclusions:
- PCNA acts as a scaffold, bringing Cdt1 and CRL4Cdt2 together at replication forks.
- This mechanism ensures timely Cdt1 destruction, preventing DNA re-replication.
- CRL4Cdt2 may also degrade other PCNA-interacting proteins, impacting cell cycle and genome stability.
Keywords:
CRL4Cdt2Cdt1Cdt2DNA re-replicationDNA repair synthesisDNA replicationPCNAReplication licensinggenome instabilityMore Related Videos
Related Concept Videos
S-Cdk Initiates DNA Replication
5.0K
The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of...
5.0K
DNA Damage can Stall the Cell Cycle
9.6K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.6K
DNA Damage Can Stall the Cell Cycle
2.8K
2.8K
Restarting Stalled Replication Forks
6.0K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.0K
Negative Regulator Molecules
37.0K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.0K
Inhibition of Cdk Activity
5.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K


